AngioDynamics (ANGO) Poised for 92.15% Rally as Wall Street Analysts Expect.

AngioDynamics (ANGO) shares have gained 0.1% over the past four weeks to close at $10.06. Wall Street analysts expect a 92.2% potential upside, with a mean estimate of $19.33. The average comprises three short-term price targets ranging from $16 to $24. The consensus price target is not always reliable, but strong agreement among analysts about better earnings strengthens the view.